We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Brown & Brown (BRO) Up 5.5% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
A month has gone by since the last earnings report for Brown & Brown (BRO - Free Report) . Shares have added about 5.5% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Brown & Brown due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Brown & Brown's Q2 Earnings, Revenues Top, Rise Y/Y
Brown & Brown, Inc.’s second-quarter 2022 adjusted earnings of 51 cents per share surpassed the Zacks Consensus Estimate as well as the year-ago quarter earnings by 4.1%.
The results reflect improved organic growth and higher commissions and fees, partly offset by higher expenses.
Q2 in Details
Total revenues of $839.7 million outpaced the Zacks Consensus Estimate by 4.4%. The top line improved 15.5% year over year. The upside can primarily be attributed to increased commission and fees, which grew 15.5% year over year to $816.6 million. Organic revenues improved 10.3% to $775.7 million in the quarter under review.
Investment income doubled year over year to $0.4 million. Adjusted EBITDAC was $274.7 million, up 16.9% year over year. EBITDAC margin expanded 30 basis points year over year to 32.7%.
Total expenses increased 18.5% to $640.9 million, courtesy of a rise in employee compensation and benefits, other operating expenses, amortization, depreciation and interest expenses.
Financial Update
Brown & Brown exited second-quarter 2022 with cash and cash equivalents of $2.4 billion, up more than three-fold from the 2021-end level. Long-term debt of $3.5 billion as of Jun 30, 2022 more than doubled from 2021 end. Net cash provided by operating activities in the first half of 2022 was $34.2 million, down 8.9% year over year.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in estimates review.
VGM Scores
At this time, Brown & Brown has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. Following the exact same course, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Brown & Brown has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
Brown & Brown is part of the Zacks Insurance - Brokerage industry. Over the past month, Marsh & McLennan (MMC - Free Report) , a stock from the same industry, has gained 7.1%. The company reported its results for the quarter ended June 2022 more than a month ago.
Marsh & McLennan reported revenues of $5.38 billion in the last reported quarter, representing a year-over-year change of +7.2%. EPS of $1.89 for the same period compares with $1.75 a year ago.
For the current quarter, Marsh & McLennan is expected to post earnings of $1.16 per share, indicating a change of +7.4% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.3% over the last 30 days.
Marsh & McLennan has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Brown & Brown (BRO) Up 5.5% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Brown & Brown (BRO - Free Report) . Shares have added about 5.5% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Brown & Brown due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Brown & Brown's Q2 Earnings, Revenues Top, Rise Y/Y
Brown & Brown, Inc.’s second-quarter 2022 adjusted earnings of 51 cents per share surpassed the Zacks Consensus Estimate as well as the year-ago quarter earnings by 4.1%.
The results reflect improved organic growth and higher commissions and fees, partly offset by higher expenses.
Q2 in Details
Total revenues of $839.7 million outpaced the Zacks Consensus Estimate by 4.4%. The top line improved 15.5% year over year. The upside can primarily be attributed to increased commission and fees, which grew 15.5% year over year to $816.6 million. Organic revenues improved 10.3% to $775.7 million in the quarter under review.
Investment income doubled year over year to $0.4 million. Adjusted EBITDAC was $274.7 million, up 16.9% year over year. EBITDAC margin expanded 30 basis points year over year to 32.7%.
Total expenses increased 18.5% to $640.9 million, courtesy of a rise in employee compensation and benefits, other operating expenses, amortization, depreciation and interest expenses.
Financial Update
Brown & Brown exited second-quarter 2022 with cash and cash equivalents of $2.4 billion, up more than three-fold from the 2021-end level. Long-term debt of $3.5 billion as of Jun 30, 2022 more than doubled from 2021 end. Net cash provided by operating activities in the first half of 2022 was $34.2 million, down 8.9% year over year.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed an upward trend in estimates review.
VGM Scores
At this time, Brown & Brown has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. Following the exact same course, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Brown & Brown has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
Brown & Brown is part of the Zacks Insurance - Brokerage industry. Over the past month, Marsh & McLennan (MMC - Free Report) , a stock from the same industry, has gained 7.1%. The company reported its results for the quarter ended June 2022 more than a month ago.
Marsh & McLennan reported revenues of $5.38 billion in the last reported quarter, representing a year-over-year change of +7.2%. EPS of $1.89 for the same period compares with $1.75 a year ago.
For the current quarter, Marsh & McLennan is expected to post earnings of $1.16 per share, indicating a change of +7.4% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.3% over the last 30 days.
Marsh & McLennan has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.